Cancer Research
Dana Dornsife, Founder and CEO of Lazarex Cancer Foundation, examines the importance of cancer clinical trials, noting that only about 5% of patients enrolled in clinical trials are from minority communities, something that needs to change. Read More ›
This is a very special issue of CONQUER: the patient voice. Many of you may not know that on an annual basis, the largest oncology organization, the American Society of Clinical Oncology—better known as ASCO—is holding a conference to discuss the most recent findings in cancer research. Read More ›
By Kelsey Moroz
After an operation to remove a rare bone cancer on his spine, Dana Vaughns never thought he would be cycling across America to raise funds for cancer research. Dana says, “Crossing the finish line with the Coast 2 Coast 4 Cancer team will be symbolic of my victory over cancer for the past 10 years.” Read More ›
By Kelsey Moroz
Obesity is associated with about 40% of cancers in the United States. This link is strongest in several types of cancer, including kidney, gastric, pancreatic, endometrial, and esophageal cancer. Significant weight reduction may help to reduce the risk for cancer. Read More ›
Diagnosed with melanoma a few weeks after her wedding, Meredith died of the disease 4 months later, at age 35. Her family created Meredith’s Mission for Melanoma, a non-profit organization, to support melanoma research and increase awareness of this deadly cancer. Read More ›
A new law in California revives the debate about coffee and cancer. However, according to the American Institute for Cancer Research, hundreds of studies show that coffee doesn’t cause cancer in humans. Read More ›
For the fourth year, Bristol-Myers Squibb employees took part in a cross-country bike ride as part of the Coast 2 Coast 4 Cancer Ride to raise money for cancer research. Read More ›
By Dana Taylor
Significant developments in the treatment of lung cancer were reported at the 2017 annual meeting of the European Society for Medical Oncology (ESMO) in Madrid, Spain. Read More ›
By Jack Aiello
Jack Aiello, multiple myeloma survivor, looks at the importance of patient advocacy and breaks down the different areas of advocacy. Read More ›
According to the Cancer Research Institute, only 3% to 6% of eligible patients with cancer participate in clinical trials in the United States. Read the reasons why clinical trials are a great option to consider. Read More ›
Page 1 of 2
- 1
- 2